Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

Recent & Breaking News (TSX:TST)

Bioniche Life Sciences Inc. Announces Key Corporate Updates

Canada NewsWire March 4, 2014

Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.

Canada NewsWire February 27, 2014

IIROC Trade Resumption - BNC

Canada NewsWire February 6, 2014

IIROC Trade Resumption - Bioniche Life Sciences Inc.

Newsfile February 6, 2014

Bioniche Life Sciences Inc. Reports Fiscal 2014 Second Quarter Results and Announces Strategic Expenditure Review and New One Health Strategy

Canada NewsWire February 6, 2014

IIROC Trading Halt - BNC

Canada NewsWire February 6, 2014

IIROC Trade Halt - Bioniche Life Sciences Inc.

Newsfile February 6, 2014

Bioniche Life Sciences Inc. Appoints a Chief Operating Officer

Canada NewsWire January 7, 2014

Bioniche Life Sciences Inc. Delisting Approved by the ASX

Canada NewsWire December 11, 2013

Primary and Long-Term Illness Related to E. coli O157 Costs $403.9 Million per Year in Canada

Canada NewsWire December 4, 2013

Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S.

Canada NewsWire December 1, 2013

Bioniche Life Sciences Inc. Reports Fiscal 2014 First Quarter Results

Canada NewsWire November 5, 2013

Bioniche Life Sciences Inc. Announces the Appointment of a New Chief Executive Officer

Canada NewsWire November 4, 2013

Bioniche Management Proxy Circular for 2013 Annual and Special Meeting Now Available

Canada NewsWire October 18, 2013

Bioniche Provides an Update on Plans for a New Drug Submission Filing in Canada

Canada NewsWire October 7, 2013

Bioniche Life Sciences Inc. Reports Fiscal 2013 Year-End Results

Canada NewsWire September 27, 2013

Bioniche Closes Canadian Equity Offering and Related Private Placement

Canada NewsWire September 26, 2013

Bioniche Files Final Prospectus for Canadian Equity Offering

Canada NewsWire September 18, 2013

IIROC Trade Resumption - Bioniche Life Sciences Inc.

Newsfile September 11, 2013

IIROC Trade Halt - Bioniche Life Sciences Inc.

Newsfile September 11, 2013